Cite
HARVARD Citation
Sullivan, J. et al. (2020). Fenfluramine HCl (Fintepla®) provides long‐term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open‐label extension study. Epilepsia. pp. 2396-2404. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sullivan, J. et al. (2020). Fenfluramine HCl (Fintepla®) provides long‐term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open‐label extension study. Epilepsia. pp. 2396-2404. [Online].